Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by Sir_Holleron Apr 14, 2015 11:49am

130 Views

Post# 23627457

RE:Quarterly Results Released

"Net income for the seven months ended December 31, 2014 was $1.2 million, compared to a net loss of $960,000 for the comparable period in the previous year."

Annualized that is $1.71 million. Divided by 12.5 million shares that is $.14 per share.

That's before the full effect of the drop in the Canadian dollar in Q1 and there was higher revenue on the last three months of the repoting period.

Bullboard Posts

Rick Rule’s election insights: Gold, USD, and Canadian gas